Post-event resources test
Masthead Headline
Thank you for joining us.
We hope that you are as inpisted as we are and excited to continue the conversation. We look forward to seeig you again next year. In the meantime, you may subscribe to receive the latest news and updates about Philips Radiology.
officia deserunt mollit
The future of maintenance: unlocking the value of big data
Body Placeholder: It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged.
deserunt
Tempus porttitor nascetur
Potenti dolor fermentum quisque torquent nisl congue nullam odio. Cursus habitasse penatibus posuere blandit imperdiet eget in senectus.
Featured collections
web.pages.event.featuredsolutions
Innovation with purpose.
This is the title that will appear on article cards across the site promoting
Dignissim massa bibendum facilisi ultrices lacinia commodo. Vivamus nisl eget hendrerit vivamus dis placerat himenaeos habitant.
web.pages.event.pressreleases
Phiips announces a new kind of robot that vacuums your fish tank
Read morePhilips launches HealthSuite Imaging, a cloud-based next generation of Vue PACS, with new AI-enabled clinical and operational workflows at #RSNA23
Read morePhilips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23
Read moreFootnotes
- Buytaert, D., et al., Evaluation of patient and staff exposure with state of the art x ray technology in cardiac catheterization: A randomized controlled trial. Journal of Interventional Cardiology, 2018. 31(6): p. 807-814. (95% CI of 53%, 77% for all diagnostic and interventional coronary procedures). The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional cardiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.
- Results based on total dose area product from a single center prospective controlled randomized study (University Hospital Gent, Belgium) on 122 patients (42 for Allura Xper and 80 for AlluraClarity) undergoing coronary procedures. Of the 122 patients, 102 (83.6%) had a diagnostic procedure without intervention and 51 (41.8%) resulted in a diagnosis of no coronary disease. Patient radiation exposure was quantified using cumulative dose area product as collected from Radiation Dose Structured Reports and/or Allura Reports. Baseline dose was maintained by configuring both systems to power up with the lowest dose settings as default and default procedure settings for cardio were used. Exam duration and fluoro time was consistent between the systems and an increase in number of exposure images and runs with the AlluraClarity was attributed to the biplane configuration compared to the monoplane configuration of the Allura Xper.
Disclaimer
Since 2016, Philips has conducted original research to help determine the readiness of countries to address global health challenges and build efficient and effective healthcare systems. The 2020 FHI report explores the perspectives of the next generation of healthcare professionals in all 15 countries. For details on the Future Health Index methodology and to access the 2020 report in its entirety, visit the Future Health Index site.